MediaShop acquires BtoC AG and the UBTC-mail order business
The German/Austrian retail group MediaShop has acquired the Swiss online retailer BtoC AG and the mail order business of UBTC Switzerland AG. The transaction was structured as a share and asset deal and marks a further cornerstone...
myneva Group acquires SWING
myneva Group, a portfolio company of Hamburg-based private equity firm BID Equity, has acquired software provider SWING headquartered in Freiburg im Breisgau (Germany) and Sursee (Switzerland). The myneva Group is a leading...
Polyneuron extends Series A Financing to CHF 36.5m
Polyneuron Pharmaceuticals AG extended its Series A by CHF 14m bringing the total to CHF 36.5m. Polyneuron is a clinical stage developer of a new class of antigen-specific polymers for the treatment of patients affected by...
AFINUM acquires Threema
AFINUM has acquired Threema GmbH, Freienbach (CH), the Swiss developer and provider of the leading European secure messenger solution for professional and personal communication. As part of this transaction, the three founders...
Polyphor grants Fosun Pharma license for balixafortide in China
Polyphor AG (SIX: POLN) and Shanghai Fosun Pharmaceutical (Group) Co. Ltd ("Fosun Pharma", stock code: 600196.SH; 02196.HK), through its Swiss affiliate Fosun Pharmaceutical AG entered into an exclusive licensing agreement for...
T3 Pharma closes 25M CHF financing round
T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based protein delivery platform, closed its third financing round, raising over 25M CHF. The financing was co-led by existing...
Polyphor enters into CHF 19.3 million equity-linked financing arrangement
Polyphor AG has entered into an equity-linked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over a period of two years. Under the financing instrument, IRIS will receive...
Seed-Financing Round with CHF 6 million by Versameb
Versameb AG has closed a CHF 6 million seed financing round. Versameb is engaged in the discovery and development of next-generation RNA-based drugs using its proprietary VERSagile technology platform developing molecules...
Bregal acquires majority stake in GUS Group
Bregal Unternehmerkapital acquired a majority stake in the Cologne-based GUS Group, one of the leading providers of enterprise software for medium-sized companies in process industries. The investment in GUS Group marks already...
Polares Medical closes a USD40M financing for pilot clinical studies
Polares Medical SA, in Lausanne, a clinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR),...